High‐grade bladder cancer: Association of the apparent diffusion coefficient with metastatic disease: Preliminary results

To assess the utility of apparent diffusion coefficient (ADC) values obtained from diffusion‐weighted imaging (DWI) in distinguishing high‐grade bladder cancer with and without metastatic disease.

[1]  Kazutaka Saito,et al.  Diagnostic performance of diffusion-weighted magnetic resonance imaging in bladder cancer: potential utility of apparent diffusion coefficient values as a biomarker to predict clinical aggressiveness , 2011, European Radiology.

[2]  A. Hartmann,et al.  The WHO classification of 1973 is more suitable than the WHO classification of 2004 for predicting survival in pT1 urothelial bladder cancer , 2011, BJU international.

[3]  B. K. Park,et al.  Prediction of biochemical recurrence following radical prostatectomy in men with prostate cancer by diffusion-weighted magnetic resonance imaging: initial results , 2011, European Radiology.

[4]  Yair Lotan,et al.  Characteristics and outcomes of patients with clinical T1 grade 3 urothelial carcinoma treated with radical cystectomy: results from an international cohort. , 2010, European urology.

[5]  Michael W Kattan,et al.  Are nomograms needed in the management of bladder cancer? , 2010, Urologic oncology.

[6]  Z. Tandoğdu,et al.  Perivesical Inflammation and Necrosis due to Mitomycin C Instillation after Transurethral Resection of Bladder Tumor: We Must Be Vigilant! , 2009, Urologia Internationalis.

[7]  J. Babb,et al.  T1 hyperintense renal lesions: characterization with diffusion-weighted MR imaging versus contrast-enhanced MR imaging. , 2009, Radiology.

[8]  P. Thall,et al.  Phase II clinical trial of neoadjuvant alternating doublet chemotherapy with ifosfamide/doxorubicin and etoposide/cisplatin in small-cell urothelial cancer. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  M. Kanematsu,et al.  Preoperative T staging of urinary bladder cancer: does diffusion-weighted MRI have supplementary value? , 2009, AJR. American journal of roentgenology.

[10]  Yuta Shibamoto,et al.  Urinary bladder cancer: diffusion-weighted MR imaging--accuracy for diagnosing T stage and estimating histologic grade. , 2009, Radiology.

[11]  Tarek El-Diasty,et al.  Bladder tumour staging: comparison of diffusion- and T2-weighted MR imaging , 2009, European Radiology.

[12]  Adilson Prando,et al.  Urinary bladder cancer: diffusion-weighted MR imaging--accuracy for diagnosing T stage and estimating histologic grade , 2009 .

[13]  D. Collins,et al.  Diffusion-weighted MRI in the body: applications and challenges in oncology. , 2007, AJR. American journal of roentgenology.

[14]  M. J. Requena Tapia,et al.  [The 2004 WHO classification of bladder tumors: a summary and commentary]. , 2007, Actas urologicas espanolas.

[15]  Toshihiro Kumabe,et al.  Malignant astrocytic tumors: clinical importance of apparent diffusion coefficient in prediction of grade and prognosis. , 2006, Radiology.

[16]  C. Sternberg.  Chemotherapy for local treatment of bladder cancer. , 2005, Seminars in radiation oncology.

[17]  C. Balch,et al.  AJCC Cancer Staging Manual. 6th ed , 2002 .

[18]  C. Compton,et al.  AJCC Cancer Staging Manual , 2002, Springer New York.

[19]  H. Ozen.  Bladder cancer. , 1998, Current opinion in oncology.

[20]  D. Paulson,et al.  Complications of radical cystectomy and urinary diversion: a retrospective review of 675 cases in 2 decades. , 1992, The Journal of urology.

[21]  U. G. Dailey.  Cancer,Facts and Figures about. , 2022, Journal of the National Medical Association.